Recently a novel suppressive function of GATA6 has been described within gastric adenocarcinoma revealing that patients with metastatic tumors had low GATA6 expression with a negative impact on the patients’ survival (Liu et al. 2019). Here, GATA6 is linked to metastatic neoplasm.